New Hope for Cancer Patients Through Photobiomodulation (PBM)

August 24, 2019

A new era of cancer treatment just dawned, giving hope to America's 15.5 million cancer survivors, and the estimated 1.8 million who will be diagnosed with cancer this year. On June 22, 2019, the Multinational Association of Supportive Care in Cancer (MASCC) recommended the use of Photobiomodulation (PBM) as the standard of care for preventing and treating the side effects of radiotherapy and chemotherapy.